Aberrant expression of platelet-derived growth factor (PDGF) and PD6F receptor-α is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis

Haematologica

Volumn 90, Issue 1, 2005, Pages 133-134

  Bock, Oliver ^a   Loch, Gero ^a   Büsche, Guntram ^a   Von Wasielewski, Reinhard ^a   Schlué, Jerome ^a   Kreipe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYELOFIBROSIS; MYELOID METAPLASIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; MYELOFIBROSIS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN ISOFORMS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 13244270141     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-65.
2. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79: 1283-316.
3. Tallquist M, Kazlauskas A. FDGF signaling in cells and mice. Cytokine Growth Factor Rev 2004;15:205-13.
4. Le Bousse-Kerdiles MC, Martyre MC. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol 1999;78:437-44.
5. Buhr T, Büsche G, Choritz H, Länger F, Kreipe H. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 2003;119:152-8.
6. Thiele J, Kvasnicka HM, Fischer R. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification. Ann Hematol 1999;78:495-506.
7. Bock O, Schlue J, Mengel M, Büsche G, Serinsöz E, Kreipe H. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders. J Pathol 2004;203:609-15
8. Keating MT, Williams LT. Autocrine stimulation of intracellular FDGF receptors in v-sis-transformed cells. Science 1988; 239:914-6.
9. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Flatelet-derived growth factor (FDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel FDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 2002;62:3729-35.